Join us for the first virtual cafe talk to hear about the amazing work that Dr. Brian Arey is doing. https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe

September 2022 "Morphine, the most widely used analgesic, relieves severe pain by activating the μ-opioid receptor (MOR), whereas naloxone, with only slight structural changes compared to morphine, exhibits inhibitory effect, and is used to treat opioid abuse. The mechanism by which the MOR distinguishes between the two is unclear. Molecular dynamics (MD) simulations on a 1-μs time scale and metadynamics-enhanced conformational sampling are used here to determine the different interactions of these two ligands with MOR: morphine adjusted its pose by continuously flipping deeper into the pocket, whereas naloxone failed to penetrate deeper because its allyl group conflicts with several residues of MOR. The endogenous peptide ligand endomorphin-1 (EM-1) underwent almost no significant conformational changes during the MD simulations. To validate these processes, we employed GIRK4S143T, a MOR-activated Gβγ-protein effector, in combination with mutagenesis and electrophysiological recordings. We verified the role of some key residues in the dynamic recognition of naloxone and morphine and identified the key residue I322, which leads to differential recognition of morphine and naloxone while assisting EM-1 in activating MOR. Reducing the side chain size of I322 (MORI322A) transformed naloxone from an inhibitor directly into an agonist of MOR, and I322A also significantly attenuated the potency of MOR on EM-1, confirming that binding deep in the pocket is critical for the agonistic effect of MOR. This finding reveals a dynamic mechanism for the response of MOR to different ligands and provides a basis for the discovery of new ligands for MOR at the atomic level." Read more at the source #DrGPCR #GPCR #IndustryNews

J Kooistra ,   David E Gloriam ,   Alexander S Hauser GPCRdb in 2025: adding odorant receptors, data J Kooistra , Gáspár Pándy-Szekeres ,   David E Gloriam , et al. Dr. GPCR Kicked Off as a Podcast... Direct line to the Dr. Jude Children's Research Hospital Welcomes Dr.

Dr. Dr. Dr. Dr. Dr.

GPCR Podcast: Leadership, Impact, and GPCR Signaling with Dr. Dr. Yamina’s open letter reflects on how Dr. I wish Dr. No matter where you are in your GPCR journey, Dr.

In this Terry’s Corner lesson, Dr. Join before year-end to secure both. 👉   Join Terry's Corner Before Dec 31st, 2025 🎧 Dr. Hudson 🎧 Catch up on Part 2 with Dr. GPCR Year in Review: Carrying Better Experiments Into 2026 As 2025 closes, the Dr. Beyond access, Premium sustains the nonprofit mission behind Dr.

Week’s GPCR Intelligence: From Set-Point Pharmacology to No-Wash Internalization Assays This week’s Dr Unlock On-Demand Yearly Access Now — Premium Members Get Over 50% Discount at Checkout ➤ Revvity x Dr GPCR: A Mission-Aligned Partnership That Advances the Field At Dr. As Dr. Eric Trinquet shares in a special Dr. I will keep Dr.

Alexander Ball and Dr. Chia-Yi Lin, began. A word that admits what it doesn’t know Much of that trust problem, Dr. Dr. Dr. Lin arrived from a different door. Listen to the full conversation with Dr. Ball and Dr. Lin Watch the webinar recording with Dr. Ball

In this week’s lesson, Dr. Access this week’s key insight ➤ Dr. Dr. 👉 Access this week’s full Premium Edition here ➤ What Members Say “Dr. See you in the Ecosystem, Dr. GPCR Team

. 🔍 This Week in Dr. In this upcoming episode, Dr. In this behind-the-scenes look, Dr. Read the full story➤ Why Dr. I wish Dr.

This week Dr. In this week's Dr. Dr. “The best pharmacology teacher (Dr. Dr.

It's spring break at Dr. Learn more about Live Masterclasses ➤ Partner Webinars Eurofins DiscoverX (Dr. GeneTex (Dr. Alex Ball)  — A reagent gap that holds back the biology. Details coming soon. Next Week in Boston The Dr. GPCR community gathers in person next week. Come find us ➤ About Dr. GPCR Dr. GPCR is the intelligence and community for GPCR scientists.

. 🔍 This Week in Dr. This week, Dr. Premium Members get a 50%+ discount when they join Terry’s Corner. 🚨 First-ever Live AMA with Dr. Unlock Terry’s Corner ➤ Dr. GPCR Podcast – Ajay Yekkirala on GPCR Innovation In this episode, Dr. Register now to secure your spot ➤ Why Dr.

Join Dr. Evan O'Brien, PhD, Johns Hopkins University Dr. Dr. Terry Kenakin, UNC and Head Instructor at Terry's Corner Dr. As Dr. Why Dr. GPCR Is in This Conversation At Dr.

Stop Chasing Affinity and Start Reading the System In this week’s cornerstone Terry’s Corner lecture, Dr As the GPCR field surges forward—from ligand bias to signaling diversity—the guest editors Dr. squarely on kinetic modeling, allosteric frameworks, and targeting the “undruggable.” 🔥 Featured:  Dr ” — Dr. GPCR Podcast Listener Why Dr. FAQ: What You Get with Dr. GPCR Premium 🔹 What’s included?

In Episode 168 of the Dr. GPCR Podcast, Dr. And that mindset is precisely what makes their new partnership with Dr. GPCR so powerful. ” — Dr. That’s the mission. ” — Dr. Maria Majellaro Now, as official partners of the Dr. Keyword Cloud:   GPCR data platform , fluorescent ligands , assay development , GPCR research community , Dr

Plus, check out the latest Dr. GPCR tools and key moves in the biotech world. Dr. Become a Dr. GPCR Ambassador - Share & refer with Dr. GPCR.   Join the Affiliate Program     Your Shortcut to Dr. The Dr. Best wishes, The Dr. GPCR Team

This week's highlight includes congrats to: Dr. Levitz for their work on Emerging modes of regulation of neuromodulatory G protein-coupled receptors Dr GPCR University We are thrilled to announce that Dr. Dr. GPCR Podcast Tune into the 156th episode of the Dr. GPCR Podcast, featuring Dr. Post-Doctoral Fellow—Pharmacology/Cell Biology/Biochemistry Post Doctoral Fellow Postdoc Position Join Dr

Dr. Maria Majellaro’s story, shared in Episode 168 of the Dr. ” — Dr. Maria Majellaro Maria didn’t always know she’d end up in a startup. ” — Dr. With the new  Dr. . 👉 Explore Celtarys’ tools and partnership with Dr.

Dr. Dr. Dr. Dr. Dr.

, we’re spotlighting Celtarys Research, our newest partner, featured in a blog and podcast with CSO Dr After 40+ years and 250 publications, Dr. Dr. Explore Terry's Corner From Chemistry Lab to GPCR Partner – New Podcast with Celtarys Dr. Stay curious, The Dr. GPCR Team

Hello Sweet GPCR Enthusiasts, This week at Dr. GPCR: a new podcast episode with Dr. Ben Clements, a tour of our official Dr. Scroll down for the science, the strategy, and the sweet stuff 🍬 Dr. The official Dr. GPCR Store is live! Best wishes, The Dr. GPCR Team

Kenakin is a masterful teacher and communicator—and a leading expert in our field.” — Dr. GPCR University Course Attendee Dr. GPCR Podcast : From Personal Pain to Scientific Purpose: Alex Serafini’s Journey We sit down with Dr. Secure your spot ➤ Why Dr. Dr.

As a valued Dr. featuring:   A short, focused video A concise written summary with key takeaways Handpicked references by Dr Your Exclusive Premium Member Benefit:   As a thank you for your continued support of the Dr. GPCR Ecosystem, we're giving Dr. Warmest Regards, The Dr. GPCR Team & Terry’s Desk

. 🔍 This Week in Dr. 🎥 Live AMA with Dr. Kenakin — October 30, 12 PM EST Bring your toughest pharmacology questions and join Dr. 50% Discount at Checkout ➤ The Innovation Trap: Why Playing It Safe Can Kill Breakthroughs Revvity's Dr Read the roundup ➤ Why Dr.

The Corner comes will live monthly AMA sessions with Dr. Kenakin. GPCR Updates Learn Pharmacology That Drives Discovery  – From Dr. Explore Dr. This blog post breaks down Dr. Stay curious,   The Dr. GPCR Team

Secure Your Access Now ➤ 🗣️ “Thank you for bringing this (Principles of Pharmacology I) course with Dr I wish Dr. best for the sake of promoting more educational opportunities that are sorely needed in the field” — Dr GPCR University Learner Dr. GPCR Podcast - Surviving Discovery’s Gauntlet Dr. The Dr. GPCR Team Read Full Edition ➤

That’s precisely what Terry’s Corner delivers each week: practical frameworks from Dr. SEP-631 for CSU; Maxion’s KnotBody® platform; a new angle on RGS protein modulation. 🔍 This Week in Dr Premium Members get a 50%+ discount when they join Terry’s Corner. 🚨 Live AMA with Dr. Register now and save with code SPK200 ➤ Why Dr. Access this week’s full Premium Edition here ➤ What our members say "Dr.

That’s precisely what Terry’s Corner delivers every week: practical tools from Dr. Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity. 🔍 This Week in Dr Premium Members get a 50%+ discount when they join Terry’s Corner. 🚨 First-ever Live AMA with Dr. This week, get to know Dr. Aaron McGrath from Takeda. He joins Dr. Register now and save with code SPK200 ➤ Why Dr.

. -            Dr. Wendy Young’s talk, during session 3 on day 2, was also incredible. . -            Dr. Wednesday was a key day for Maria, as she got to participate in a panel discussion alongside Dr. Shoichet, Dr. Luc Van Hijfte and Dr. Wendy Young. Amanda Dombrowski from Abbvie, Dr. Charles Yeung from Merck and Dr.